Spasticity: Clinical Trials

2 trials for Spasticity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 32Terminated 2

Follow Spasticity: new trials by email Literature Review of Spasticity trials Research Report on Spasticity

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
Phase 2; Low Dose MYOBLOC (10,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo - Spasticity, Cerebrovascular Accident
Phase 2 / Phase 3TerminatedSolstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC322021-11-022026-05-27
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity
Phase 2; Low Dose MYOBLOC (15,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo - Spasticity
Phase 2 / Phase 3TerminatedSolstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC402019-12-172026-05-22

Narrower conditions

Brain Injuries, Traumatic (2)  ·  Hemiplegia (2)  ·  Muscle Spasticity (2)  ·  Stroke (2)  ·  Cerebral Palsy (1)  ·  Multiple Sclerosis (1)

Broader conditions

Brain Diseases (2)  ·  Brain Injuries (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Craniocerebral Trauma (2)  ·  Muscle Hypertonia (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Neuromuscular Manifestations (2)  ·  Paralysis (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)

Interventions

Clinical Trials, Phase II as Topic (2)  ·  Clinical Trials, Phase III as Topic (2)  ·  rimabotulinumtoxinB (2)

Sponsors

Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC (2)

Countries

Hungary (2)  ·  Poland (2)  ·  United States (2)

Top investigators

Joseph T Hull, PhD (2)